Clinically Relevant Chemotherapeutics Have the Ability to Induce Immunogenic Cell Death in Non-Small Cell Lung Cancer

被引:42
|
作者
Flieswasser, Tal [1 ,2 ]
Van Loenhout, Jinthe [1 ]
Freire Boullosa, Laurie [1 ]
Van den Eynde, Astrid [1 ]
De Waele, Jorrit [1 ]
Van Audenaerde, Jonas [1 ]
Lardon, Filip [1 ]
Smits, Evelien [1 ,3 ]
Pauwels, Patrick [1 ,2 ]
Jacobs, Julie [1 ,2 ]
机构
[1] Integrated Personalized & Precis Oncol Network IP, Ctr Oncol Res CORE, B-2610 Antwerp, Belgium
[2] Antwerp Univ Hosp, Dept Pathol, B-2650 Edegem, Belgium
[3] Antwerp Univ Hosp, Ctr Cell Therapy & Regenerat Med, B-2650 Edegem, Belgium
关键词
non-small cell lung cancer; chemotherapy; immunogenic cell death; ENDOPLASMIC-RETICULUM STRESS; CALRETICULIN EXPOSURE; TARGETED THERAPIES; IN-VITRO; CISPLATIN; PEMBROLIZUMAB; EFFICACY; MULTICENTER; ACTIVATION; RESISTANCE;
D O I
10.3390/cells9061474
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The concept of immunogenic cell death (ICD) has emerged as a cornerstone of therapy-induced anti-tumor immunity. To this end, the following chemotherapies were evaluated for their ability to induce ICD in non-small cell lung cancer (NSCLC) cell lines: docetaxel, carboplatin, cisplatin, oxaliplatin and mafosfamide. The ICD hallmarks ATP, ecto-calreticulin, HMGB1, phagocytosis and maturation status of dendritic cells (DCs) were assessed in vitro. Furthermore, an in vivo vaccination assay on C57BL/6J mice was performed to validate our in vitro results. Docetaxel and the combination of docetaxel with carboplatin or cisplatin demonstrated the highest levels of ATP, ecto-calreticulin and HMGB1 in three out of four NSCLC cell lines. In addition, these regimens resulted in phagocytosis of treated NSCLC cells and maturation of DCs. Along similar lines, all mice vaccinated with NSCLC cells treated with docetaxel and cisplatin remained tumor-free after challenge. However, this was not the case for docetaxel, despite its induction of the ICD-related molecules in vitro, as it failed to reject tumor growth at the challenge site in 60% of the mice. Moreover, our in vitro and in vivo data show the inability of oxaliplatin to induce ICD in NSCLC cells. Overall with this study we demonstrate that clinically relevant chemotherapeutic regimens in NSCLC patients have the ability to induce ICD.
引用
收藏
页码:1 / 17
页数:17
相关论文
共 50 条
  • [1] The Ability of Clinically Relevant Chemotherapeutics to Induce Immunogenic Cell Death in Squamous Cell Carcinoma
    He, Zhenjie
    Jing, Xinming
    Dai, Xiaoyan
    Bao, Lingbo
    Yang, Xiao
    Xiong, Yanli
    Li, Mengxia
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2024, 29 (04):
  • [2] Crizotinib-induced immunogenic cell death in non-small cell lung cancer
    Liu, Peng
    Zhao, Liwei
    Pol, Jonathan
    Levesque, Sarah
    Petrazzuolo, Adriana
    Pfirschke, Christina
    Engblom, Camilla
    Rickelt, Steffen
    Yamazaki, Takahiro
    Iribarren, Kristina
    Senovilla, Laura
    Bezu, Lucillia
    Vacchelli, Erika
    Sica, Valentina
    Melis, Andrea
    Martin, Tiffany
    Lin, Xia
    Yang, Heng
    Li, Qingqing
    Chen, Jinfeng
    Durand, Sylvere
    Aprahamian, Fanny
    Lefevre, Deborah
    Broutin, Sophie
    Paci, Angelo
    Bongers, Amaury
    Minard-Colin, Veronique
    Tartour, Eric
    Zitvogel, Laurence
    Apetoh, Lionel
    Ma, Yuting
    Pittet, Mikael J.
    Kepp, Oliver
    Kroemer, Guido
    [J]. NATURE COMMUNICATIONS, 2019, 10 (1)
  • [3] Crizotinib-induced immunogenic cell death in non-small cell lung cancer
    Peng Liu
    Liwei Zhao
    Jonathan Pol
    Sarah Levesque
    Adriana Petrazzuolo
    Christina Pfirschke
    Camilla Engblom
    Steffen Rickelt
    Takahiro Yamazaki
    Kristina Iribarren
    Laura Senovilla
    Lucillia Bezu
    Erika Vacchelli
    Valentina Sica
    Andréa Melis
    Tiffany Martin
    Lin Xia
    Heng Yang
    Qingqing Li
    Jinfeng Chen
    Sylvère Durand
    Fanny Aprahamian
    Deborah Lefevre
    Sophie Broutin
    Angelo Paci
    Amaury Bongers
    Veronique Minard-Colin
    Eric Tartour
    Laurence Zitvogel
    Lionel Apetoh
    Yuting Ma
    Mikael J. Pittet
    Oliver Kepp
    Guido Kroemer
    [J]. Nature Communications, 10
  • [4] (-)-Guaiol triggers immunogenic cell death and inhibits tumor growth in non-small cell lung cancer
    Yang, Xiaohui
    Yang, Junling
    Gu, Xiaoxia
    Tao, Yuhua
    Ji, Hongjuan
    Miao, Xian
    Shen, Shuijie
    Zang, Haiyang
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 2023, 478 (07) : 1611 - 1620
  • [5] Author Correction: Crizotinib-induced immunogenic cell death in non-small cell lung cancer
    Peng Liu
    Liwei Zhao
    Jonathan Pol
    Sarah Levesque
    Adriana Petrazzuolo
    Christina Pfirschke
    Camilla Engblom
    Steffen Rickelt
    Takahiro Yamazaki
    Kristina Iribarren
    Laura Senovilla
    Lucillia Bezu
    Erika Vacchelli
    Valentina Sica
    Andréa Melis
    Tiffany Martin
    Lin Xia
    Heng Yang
    Qingqing Li
    Jinfeng Chen
    Sylvère Durand
    Fanny Aprahamian
    Deborah Lefevre
    Sophie Broutin
    Angelo Paci
    Amaury Bongers
    Veronique Minard-Colin
    Eric Tartour
    Laurence Zitvogel
    Lionel Apetoh
    Yuting Ma
    Mikael J. Pittet
    Oliver Kepp
    Guido Kroemer
    [J]. Nature Communications, 10
  • [6] (−)-Guaiol triggers immunogenic cell death and inhibits tumor growth in non-small cell lung cancer
    Xiaohui Yang
    Junling Yang
    Xiaoxia Gu
    Yuhua Tao
    Hongjuan Ji
    Xian Miao
    Shuijie Shen
    Haiyang Zang
    [J]. Molecular and Cellular Biochemistry, 2023, 478 : 1611 - 1620
  • [7] Incidence of clinically relevant hyperglycaemia in patients with non-small cell lung cancer treated with immunotherapy
    Farag, S.
    Moore, B.
    Mulla, K.
    Yousaf, N.
    Popat, S.
    Morganstein, D.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S1081 - S1081
  • [8] Immunogenic targets in non-small cell lung cancer: More is more
    Gnjatic, S
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (15) : 5331 - 5332
  • [9] Crizotinib-induced immunogenic cell death in non-small cell lung cancer (vol 10, 1486, 2019)
    Liu, Peng
    Zhao, Liwei
    Pol, Jonathan
    Levesque, Sarah
    Petrazzuolo, Adriana
    Pfirschke, Christina
    Engblom, Camilla
    Rickelt, Steffen
    Yamazaki, Takahiro
    Iribarren, Kristina
    Senovilla, Laura
    Bezu, Lucillia
    Vacchelli, Erika
    Sica, Valentina
    Melis, Andrea
    Martin, Tiffany
    Xia, Lin
    Yang, Heng
    Li, Qingqing
    Chen, Jinfeng
    Durand, Sylvere
    Aprahamian, Fanny
    Lefevre, Deborah
    Broutin, Sophie
    Paci, Angelo
    Bongers, Amaury
    Minard-Colin, Veronique
    Tartour, Eric
    Zitvogel, Laurence
    Apetoh, Lionel
    Ma, Yuting
    Pittet, Mikael J.
    Kepp, Oliver
    Kroemer, Guido
    [J]. NATURE COMMUNICATIONS, 2019, 10 (1)
  • [10] PRIMA-1 synergizes with adriamycin to induce cell death in non-small cell lung cancer cells
    Magrini, R.
    Russo, D.
    Ottaggio, L.
    Fronza, G.
    Inga, A.
    Menichini, P.
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2008, 104 (06) : 2363 - 2373